Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
XSpray Pharma AB
XSPRAYCurrent price
44 SEK
+1.7 SEK (+4.02%)
Last closed
43.2 SEK
Company
www.xspraypharma.com
ISIN
SE0009973563
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
1 637 955 439 SEK
Yield for 12 month
+11.68 %
1Y
3Y
5Y
10Y
15Y
XSPRAY
Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company's product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has partnership agreements with EVERSANA for the commercialization of Dasynoc, as well as with NerPharMa for commercial production of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden. Address: Scheeles vAeg 2, Solna, Sweden, 171 65
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
967.3 SEKP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+942 908 SEK
Last Quarter
+135 862 SEK
Current Year
-9 321 646 SEK
Last Year
-9 664 344 SEK
Current Quarter
-1 438 704 SEK
Last Quarter
-2 602 640 SEK
Key Figures XSPRAY
1 year
3 years
5 years
10 years
EBITDA
-211 311 604 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.76 %
PEG Ratio
–
Return On Equity TTM
-37.74 %
Wall Street Target Price
967.3 SEK
Revenue TTM
-198 721 SEK
Book Value
22.5 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
665 108 SEK
Earnings per share
-8 SEK
Diluted Eps TTM
-8 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics XSPRAY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XSPRAY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XSPRAY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
50.7711
Enterprise Value EBITDA
-7.0133
Price Book MRQ
2.6983
Financials XSPRAY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XSPRAY
For 52 weeks
33.46 SEK
92.97 SEK
50 Day MA
52.67 SEK
Shares Short Prior Month
–
200 Day MA
54.36 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart